Beckman Coulter Life Sciences said today it has acquired single-cell data analysis and software-as-a-service company Cytobank for an undisclosed amount. 

Cytobank, based in Santa Clara, California, provides a cloud- and machine learning-based software platform for multi-parametric single-cell data analysis, sharing, and archiving. Its technology enables researchers to conduct high-dimensional multi-omics data analysis, visualization, and collaboration across multiple sites. The privately held firm was founded in 2007 in the laboratory of Garry Nolan at Stanford.

According to Beckman Coulter, Cytobank's technology "pairs naturally" with the firm CytoFlex LX 21-color flow cytometer. The acquisition allows Beckman Coulter, a Danaher business based in Indianapolis, to "provide more standardized, yet flexible high-end data analytics solution pharma/biopharma and leading academic clinical research customers," Mario Koksch, flow cytometry business unit vice president and general manager, Beckman Coulter Life Sciences, said in a statement.